Steroid Hormone API Market Report – Research, Industry Analysis Reports and Market Demands

Global Steroid Hormone API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Steroid Hormone API Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Prednisone Series
- 1.3.3 Dexamethasone Series
- 1.3.4 Betamethasone Series
- 1.3.5 Hydrocortisone Series
- 1.3.6 Sex Hormones Series
- 1.3.7 Other
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Steroid Hormone API Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Injectable Drugs
- 1.4.3 Oral Drugs
- 1.4.4 Topical Drugs
- 1.4.5 Inhaled Drugs
1.5 Global Steroid Hormone API Market Size & Forecast
- 1.5.1 Global Steroid Hormone API Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Steroid Hormone API Sales Quantity (2021-2032)
- 1.5.3 Global Steroid Hormone API Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Steroid Hormone API by Manufacturer

3.1 Global Steroid Hormone API Sales Quantity by Manufacturer (2021-2026)
3.2 Global Steroid Hormone API Revenue by Manufacturer (2021-2026)
3.3 Global Steroid Hormone API Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Steroid Hormone API by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Steroid Hormone API Manufacturer Market Share in 2025
- 3.4.3 Top 6 Steroid Hormone API Manufacturer Market Share in 2025
3.5 Steroid Hormone API Market: Overall Company Footprint Analysis
- 3.5.1 Steroid Hormone API Market: Region Footprint
- 3.5.2 Steroid Hormone API Market: Company Product Type Footprint
- 3.5.3 Steroid Hormone API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Steroid Hormone API Market Size by Region
- 4.1.1 Global Steroid Hormone API Sales Quantity by Region (2021-2032)
- 4.1.2 Global Steroid Hormone API Consumption Value by Region (2021-2032)
- 4.1.3 Global Steroid Hormone API Average Price by Region (2021-2032)
4.2 North America Steroid Hormone API Consumption Value (2021-2032)
4.3 Europe Steroid Hormone API Consumption Value (2021-2032)
4.4 Asia-Pacific Steroid Hormone API Consumption Value (2021-2032)
4.5 South America Steroid Hormone API Consumption Value (2021-2032)
4.6 Middle East & Africa Steroid Hormone API Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Steroid Hormone API Sales Quantity by Type (2021-2032)
5.2 Global Steroid Hormone API Consumption Value by Type (2021-2032)
5.3 Global Steroid Hormone API Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Steroid Hormone API Sales Quantity by Application (2021-2032)
6.2 Global Steroid Hormone API Consumption Value by Application (2021-2032)
6.3 Global Steroid Hormone API Average Price by Application (2021-2032)

7 North America

7.1 North America Steroid Hormone API Sales Quantity by Type (2021-2032)
7.2 North America Steroid Hormone API Sales Quantity by Application (2021-2032)
7.3 North America Steroid Hormone API Market Size by Country
- 7.3.1 North America Steroid Hormone API Sales Quantity by Country (2021-2032)
- 7.3.2 North America Steroid Hormone API Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Steroid Hormone API Sales Quantity by Type (2021-2032)
8.2 Europe Steroid Hormone API Sales Quantity by Application (2021-2032)
8.3 Europe Steroid Hormone API Market Size by Country
- 8.3.1 Europe Steroid Hormone API Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Steroid Hormone API Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Steroid Hormone API Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Steroid Hormone API Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Steroid Hormone API Market Size by Region
- 9.3.1 Asia-Pacific Steroid Hormone API Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Steroid Hormone API Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Steroid Hormone API Sales Quantity by Type (2021-2032)
10.2 South America Steroid Hormone API Sales Quantity by Application (2021-2032)
10.3 South America Steroid Hormone API Market Size by Country
- 10.3.1 South America Steroid Hormone API Sales Quantity by Country (2021-2032)
- 10.3.2 South America Steroid Hormone API Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Steroid Hormone API Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Steroid Hormone API Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Steroid Hormone API Market Size by Country
- 11.3.1 Middle East & Africa Steroid Hormone API Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Steroid Hormone API Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Steroid Hormone API Market Drivers
12.2 Steroid Hormone API Market Restraints
12.3 Steroid Hormone API Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Steroid Hormone API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Steroid Hormone API
13.3 Steroid Hormone API Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Steroid Hormone API Typical Distributors
14.3 Steroid Hormone API Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Steroid Hormone API market size was valued at US$ 3103 million in 2025 and is forecast to a readjusted size of US$ 4515 million by 2032 with a CAGR of 5.6% during review period.
Steroid Hormone APIs are active pharmaceutical ingredients based on the steroid backbone, encompassing subcategories such as sex hormones (e.g., estrogen, progesterone, testosterone) and adrenal corticosteroids (glucocorticoids, mineralocorticoids). They are widely used clinically for endocrine regulation, anti-inflammatory and immunosuppressive therapy, contraception, and hormone replacement therapy. Steroid hormone APIs are typically supplied in raw material form for the production of oral, injectable, and topical formulations, serving as essential building blocks in modern pharmaceuticals and biopharmaceuticals. In 2024, the global average price of Steroid Hormone APIs was USD 593 per kilogram, with a total sales volume of 4,794 tons.
The Steroid Hormone API market has experienced steady growth in recent years, driven largely by global clinical demand for corticosteroids and sex hormone drugs. These APIs are widely applied in therapies such as anti-inflammatory, immunosuppressive, endocrine regulation, hormone replacement, and anti-allergic treatments, covering injectable, oral, and topical formulations. The global market is dominated by a few multinational pharmaceutical companies, including Pfizer, EUROAPI, and GlaxoSmithKline, while Chinese manufacturers hold advantages in medium- to low-end steroidal API production and dominate the supply of initial and intermediate products, providing a stable source of raw materials for the global market.Looking ahead, the Steroid Hormone API market is expected to shift toward high-end, technology-intensive products, particularly for advanced corticosteroid derivatives with enhanced efficacy, safety, and multifunctionality. The adoption of automated, continuous, and green manufacturing technologies will improve production efficiency and product quality. Furthermore, the rise of personalized medicine and precision therapies will drive demand for customized, high-value steroidal APIs. China's advantages in raw material supply and production technology are likely to attract more multinational production and R&D activities, accelerating industrial upgrading and global market integration.Key drivers include sustained clinical demand for anti-inflammatory, immunomodulatory, and hormone replacement therapies, the aging population and increasing chronic disease prevalence, and China's competitive edge in raw materials, production cost, and integrated supply chains. Technological innovation and supportive policies also bolster market expansion. However, challenges remain, such as the high R&D barrier for advanced steroidal APIs, stringent international quality and certification requirements, complex production processes with strict regulatory oversight, as well as raw material price volatility and environmental pressures. These factors collectively pose challenges for companies in R&D capability, production efficiency, and global market positioning.
This report is a detailed and comprehensive analysis for global Steroid Hormone API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Steroid Hormone API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Steroid Hormone API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Steroid Hormone API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Steroid Hormone API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Steroid Hormone API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Steroid Hormone API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer CentreOne, EUROAPI, GlaxoSmithKline, TAPI, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, Anuh Pharma, Symbiotec Pharmalab, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Steroid Hormone API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Sex Hormones Series
Other
Market segment by Application
Injectable Drugs
Oral Drugs
Topical Drugs
Inhaled Drugs
Major players covered
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
TAPI
Hovione
Axplora
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Wellona Pharma
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
Tianjin Pacific Pharmaceutical
Shandong Xinhua Pharmaceutica Group
Jiangsu Lianhuan Pharmaceutical
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Saituo Biological Technology
Zhejiang Xianju Junye Pharmaceutical
Tianjin Jinhui Pharmaceutical Group
Tianjin Xinyi Jinjin Pharmaceutical
Xi'an Guokang Ruijin Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Steroid Hormone API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Steroid Hormone API, with price, sales quantity, revenue, and global market share of Steroid Hormone API from 2021 to 2026.
Chapter 3, the Steroid Hormone API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Steroid Hormone API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Steroid Hormone API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Steroid Hormone API.
Chapter 14 and 15, to describe Steroid Hormone API sales channel, distributors, customers, research findings and conclusion.

Buy now